BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15455354)

  • 1. Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors.
    Cabrera CM; López-Nevot MA; Jiménez P; Garrido F
    Int J Cancer; 2005 Feb; 113(4):611-8. PubMed ID: 15455354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of HLA-B44 allelic losses in human solid tumors.
    Cabrera T; Maleno I; Lopez-Nevot MA; Redondo M; Fernandez MA; Collado A; Garrido F
    Hum Immunol; 2003 Oct; 64(10):941-50. PubMed ID: 14522091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading.
    Peh CA; Burrows SR; Barnden M; Khanna R; Cresswell P; Moss DJ; McCluskey J
    Immunity; 1998 May; 8(5):531-42. PubMed ID: 9620674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B44 polymorphisms at position 116 of the heavy chain influence TAP complex binding via an effect on peptide occupancy.
    Thammavongsa V; Raghuraman G; Filzen TM; Collins KL; Raghavan M
    J Immunol; 2006 Sep; 177(5):3150-61. PubMed ID: 16920953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the MHC class I peptide cargo is dependent on tapasin.
    Williams AP; Peh CA; Purcell AW; McCluskey J; Elliott T
    Immunity; 2002 Apr; 16(4):509-20. PubMed ID: 11970875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
    Ogino T; Bandoh N; Hayashi T; Miyokawa N; Harabuchi Y; Ferrone S
    Clin Cancer Res; 2003 Sep; 9(11):4043-51. PubMed ID: 14519625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass Spectrometric Profiling of HLA-B44 Peptidomes Provides Evidence for Tapasin-Mediated Tryptophan Editing.
    Kaur A; Surnilla A; Zaitouna AJ; Mumphrey MB; Basrur V; Grigorova I; Cieslik M; Carrington M; Nesvizhskii AI; Raghavan M
    J Immunol; 2023 Nov; 211(9):1298-1307. PubMed ID: 37737643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
    Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; Cabrera CM; Cabrera T; Paco L; López-Nevot MA; Collado A; Ferrón A; Garrido F
    Immunogenetics; 2004 Jul; 56(4):244-53. PubMed ID: 15258706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines.
    Seliger B; Schreiber K; Delp K; Meissner M; Hammers S; Reichert T; Pawlischko K; Tampé R; Huber C
    Tissue Antigens; 2001 Jan; 57(1):39-45. PubMed ID: 11169257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
    Maleno I; Romero JM; Cabrera T; Paco L; Aptsiauri N; Cozar JM; Tallada M; López-Nevot MA; Garrido F
    Immunogenetics; 2006 Jul; 58(7):503-10. PubMed ID: 16705407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative differences in peptides bound to HLA-B27 in the presence of mouse versus human tapasin define a role for tapasin as a size-dependent peptide editor.
    Sesma L; Galocha B; Vázquez M; Purcell AW; Marcilla M; McCluskey J; López de Castro JA
    J Immunol; 2005 Jun; 174(12):7833-44. PubMed ID: 15944288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of tapasin gene restores surface expression of HLA class I molecules, but not antigen presentation of an HIV envelope peptide in a hepatoma cell line.
    Matsui M; Machida S; Tomiyama H; Takiguchi M; Akatsuka T
    Biochem Biophys Res Commun; 2001 Jul; 285(2):508-17. PubMed ID: 11444872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different mechanisms can lead to the same altered HLA class I phenotype in tumors.
    Rodriguez T; Aptsiauri N; Méndez R; Jimenez P; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2007 Apr; 69 Suppl 1():259-63. PubMed ID: 17445215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new HLA-B44 allele (B*44020102S) with a splicing mutation leading to a complete deletion of exon 5.
    Dubois V; Tiercy JM; Labonne MP; Dormoy A; Gebuhrer L
    Tissue Antigens; 2004 Feb; 63(2):173-80. PubMed ID: 14705988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
    Cabrera T; Salinero J; Fernandez MA; Garrido A; Esquivias J; Garrido F
    Hum Immunol; 2000 May; 61(5):499-506. PubMed ID: 10773352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extra molecule in addition to human tapasin is required for surface expression of beta2m linked HLA-B4402 on murine cell.
    Flutter B; Fu HM; Wedderburn L; Gao B
    Mol Immunol; 2007 Jul; 44(14):3528-36. PubMed ID: 17498802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tapasin decreases immune responsiveness to a model tumor antigen.
    Turnquist HR; Kohlgraf KG; McIlhaney MM; Mosley RL; Hollingsworth MA; Solheim JC
    J Clin Immunol; 2004 Jul; 24(4):462-70. PubMed ID: 15163903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a functional, soluble tapasin protein from an alternatively spliced mRNA.
    Gao B; Williams A; Sewell A; Elliott T
    Genes Immun; 2004 Mar; 5(2):101-8. PubMed ID: 14668790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
    Ramal LM; Maleno I; Cabrera T; Collado A; Ferron A; Lopez-Nevot MA; Garrido F
    Hum Immunol; 2000 Oct; 61(10):1001-12. PubMed ID: 11082513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.